snakker.
Investor briefing · 2026

Every market deserves its own conversation.

AI-native interactive communication, built inside one of the hardest industries to enter.

The AI wave

Everyone wants a piece of AI. Few have walls around it.

Most AI companies are one model release away from being a feature. Anyone can build what they build.

We're AI-native in pharma, where regulation, medical accuracy and MLR keep the tourists out.

Thin AI AI at the core → ↑ Hard to enter Easy to enter
Pharma agencies
AI content tools
Generic agencies
Snakker

The problem

In a country affiliate, a brand manager knows exactly what her doctors need to hear.

Their objections. Their language. The study they haven't read.

What she doesn't have is the budget, six months of agency process, or permission to change the global campaign.

So her doctors get the same PDF as everyone else.

Why it's built this way

Two good reasons to centralise.

Scale. One thing made a thousand times was cheaper than a thousand things.

Control. In a regulated industry, one central process was the only safe way to stay compliant.

Both were true for fifty years.

Neither is true anymore

When one tailored piece costs what a thousand identical ones cost, scale stops being an argument.

When AI checks every claim against the approved source before a human sees it, control no longer needs a centre.

Central standards.
Local conversations.

What we are

We look like an agency.
We are not one.

50%

Service

  • A team that sits with the brand
  • Moves at the client's speed
  • Knows MLR from the inside
50%

Technology

  • Software we build ourselves
  • Agentic systems for one industry
  • Gets better with every job

Watch it build

SNAKKER STUDIO · ILLUSTRATIVE RUN

Brief

  1. StudioArgument: 5 questions, rising stakes
  2. StudioInteraction: scored evidence challenge
  3. StudioDesign: dark, starfield, one accent
  4. MissionCompiled to code · tests passing
  5. MLRClaims traced to source · 1 flagged for review
  6. MissionTracking instrumented · deployed
The 'Just an itch?' Snak
Live · tracking every interaction

The machine

Generative freedom. Engineering discipline.

Brief

The problem, the audience, the approved sources

Studio

Argument, psychology, design, interaction

Mission

Real code, tested, instrumented

MLR pre-check

Every claim traced. We predict pushback, humans approve

Live

Tracked in market, every interaction

The work

Not slides.
Experiences.

Short, interactive pieces that turn complex science into something a doctor actually wants to finish.

Quizzes, games, films, calculators, surveys. All real, all shipped, for clients across dermatology, oncology, ophthalmology and dental.

Because of the tech

One engine. Every format.

A new format is new instructions for the engine, not a new department. That's why we can go anywhere there's a screen.

Columvi data film in Mandarin
FilmsData films in Mandarin, delivered for China
Live
Mind the gap survey
SurveysAffiliate research
Live

The price

€800

per Snak. Nothing more. Nothing less.

First version in 48 hoursTracking includedMLR pre-checked

The storefront

Order a Snak like you order a burger.

Concept for snakker.io. Pick what you need. Every combination costs the same.

snakker.io/order
snakker.Work · How it works · Order

Build your Snak.

Answer five things. We'll get back to you within 48 hours.

01

What's the challenge?

GPs refer too late. They don't see when eczema is more than an itch.
02

Who's it for?

03

What should it be?

04

Where?

05

What can you give us?

SmPC.pdfKey study.pdfBrand guide.pdf

Already live with

LEO PharmaAbbVieSolventumBoehringer IngelheimRoche via Havas
168Snaks built
[X]markets & languages
[X]revenue · repeat clients

Why no one catches us

Anyone can open ChatGPT. Nobody else has this.

01168 Snaks of accumulated method
02An MLR layer that predicts where reviewers push back
03Production that turns output into verified, measurable code
04Every real client round, built back into the system

Our moat is building the next moat before the last one is gone.

What the money builds

Our own model. Trained on our method. Hosted in Europe.

Built on Mistral. European, open-weight, ours to host and tune.
Trained on what only we have. 168 Snaks, their briefs, and every review round.
Data stays in the EU. The answer pharma procurement wants to hear.
Cheaper with every run. No vendor can switch it off or reprice it.

The ask

€[X]

Use of funds

The Snakker model on Mistral[X]%Training, EU hosting, evaluation against today's models
The storefront[X]%Order to first version in 48 hours, without a meeting
New formats[X]%IVAs and video at scale
Go to market[X]%Pharma affiliates first, then medtech and beyond

    Milestones

  1. 01[Milestone 1]
  2. 02[Milestone 2]
  3. 03[Milestone 3]

Next month, she describes her problem in five minutes.

Two days later her doctors are playing with something made for them, in their language, checked against her approved claims.

For €800.

Every market deserves its own conversation.
We're making that possible.

← → navigate · N notes · F fullscreen